Back to mobile site

Vir Biotechnology (VIR) PT Raised to $200 at H.C. Wainwright

November 30, 2021 9:17 AM EST Send to a Friend
H.C. Wainwright analyst Patrick Trucchio raised the price target on Vir Biotechnology (NASDAQ: VIR) to $200.00 (from $135.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login